Singapore markets open in 1 hour 22 minutes
  • Straits Times Index

    2,998.77
    +2.85 (+0.10%)
     
  • S&P 500

    3,851.85
    +52.94 (+1.39%)
     
  • Dow

    31,188.38
    +257.86 (+0.83%)
     
  • Nasdaq

    13,457.25
    +260.07 (+1.97%)
     
  • BTC-USD

    35,599.60
    +1,199.63 (+3.49%)
     
  • CMC Crypto 200

    696.42
    -4.19 (-0.60%)
     
  • FTSE 100

    6,740.39
    +27.44 (+0.41%)
     
  • Gold

    1,870.70
    +4.20 (+0.23%)
     
  • Crude Oil

    53.28
    +0.04 (+0.08%)
     
  • 10-Yr Bond

    1.0900
    -0.0020 (-0.18%)
     
  • Nikkei

    28,523.26
    -110.20 (-0.38%)
     
  • Hang Seng

    29,962.47
    +320.19 (+1.08%)
     
  • FTSE Bursa Malaysia

    1,601.54
    -0.34 (-0.02%)
     
  • Jakarta Composite Index

    6,429.76
    +107.90 (+1.71%)
     
  • PSE Index

    7,143.30
    -55.15 (-0.77%)
     

Geron to Present at the BTIG Virtual Biotechnology Conference

·1-min read

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Tuesday, August 11, 2020 at 12:30 p.m. ET.

A live audio webcast of the presentation will be available on Geron’s website, www.geron.com/investors/events. If you are unable to listen to the live presentation, an archived webcast will be available on the Company’s website for 30 days.

About Geron

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200804005949/en/

Contacts

Suzanne Messere
Investor and Media Relations
investor@geron.com
media@geron.com